Impact of low-dose rituximab on splenic B cells: evidence for the shaving reaction.
Taylor
Ronald P
RP
Lindorfer
Margaret A
MA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D001402:B-Lymphocytes / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008212:Lymphocyte Depletion; D000069283:Rituximab; D013154:Spleen / Q000276:immunology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab